MX2023008097A - Composicion farmaceutica oftalmica y lentes de contacto de administracion de farmacos. - Google Patents

Composicion farmaceutica oftalmica y lentes de contacto de administracion de farmacos.

Info

Publication number
MX2023008097A
MX2023008097A MX2023008097A MX2023008097A MX2023008097A MX 2023008097 A MX2023008097 A MX 2023008097A MX 2023008097 A MX2023008097 A MX 2023008097A MX 2023008097 A MX2023008097 A MX 2023008097A MX 2023008097 A MX2023008097 A MX 2023008097A
Authority
MX
Mexico
Prior art keywords
drug delivery
contact lens
delivery contact
present
pharmaceutical composition
Prior art date
Application number
MX2023008097A
Other languages
English (en)
Inventor
Ok Chan Jeong
Du Hyung Choi
Ah Ram Lee
Sang Wook Park
Original Assignee
Daewon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewon Pharmaceutical Co Ltd filed Critical Daewon Pharmaceutical Co Ltd
Publication of MX2023008097A publication Critical patent/MX2023008097A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una lente de contacto para la administración de fármacos que tiene una eficacia y una biodisponibilidad de administración de fármacos mejoradas. Con la capacidad de liberar un fármaco de forma estable, la lente de contacto de administración de fármacos según la presente invención reduce la dosis y la frecuencia de dosificación, en comparación con los colirios conocidos convencionalmente, y por lo tanto se puede esperar que presente una biodisponibilidad mejorada. Además, la lente de contacto para administración de fármacos según la presente invención se puede aplicar fácilmente a diversos fármacos, presenta poca irritación ocular y es ventajosa para la producción en masa debido a u n método de preparación fácil para los mismos.
MX2023008097A 2021-01-08 2022-01-07 Composicion farmaceutica oftalmica y lentes de contacto de administracion de farmacos. MX2023008097A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20210002689 2021-01-08
PCT/KR2022/000314 WO2022149914A1 (ko) 2021-01-08 2022-01-07 약물전달용 콘택트렌즈 및 안과용 약학적 조성물

Publications (1)

Publication Number Publication Date
MX2023008097A true MX2023008097A (es) 2023-07-14

Family

ID=82358269

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023008097A MX2023008097A (es) 2021-01-08 2022-01-07 Composicion farmaceutica oftalmica y lentes de contacto de administracion de farmacos.

Country Status (9)

Country Link
US (1) US20240033124A1 (es)
EP (1) EP4275675A1 (es)
JP (1) JP2024502964A (es)
KR (1) KR20220100541A (es)
CN (1) CN116761630A (es)
AU (1) AU2022205341A1 (es)
CA (1) CA3204104A1 (es)
MX (1) MX2023008097A (es)
WO (1) WO2022149914A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102631008B1 (ko) * 2023-12-27 2024-01-30 이하리 화장료 조성물 및 이의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068281A2 (en) * 2008-12-11 2010-06-17 Massachusetts Institute Of Technology Contact lens drug delivery device
KR101877031B1 (ko) * 2016-12-30 2018-07-11 주식회사 윈스 약물이 담지된 콘택트렌즈
KR101860667B1 (ko) 2017-04-12 2018-05-24 조선대학교산학협력단 라소자임 감응 약물 전달용 하이드로겔 콘택트렌즈 및 그 제조방법
CN114296256A (zh) * 2017-05-01 2022-04-08 普雷斯拜视力有限公司 动态泪液透镜
KR102009571B1 (ko) * 2017-11-06 2019-08-09 대구가톨릭대학교산학협력단 온도감응성 약물전달용 하이드로겔 콘택트렌즈 및 그 제조방법

Also Published As

Publication number Publication date
CN116761630A (zh) 2023-09-15
EP4275675A1 (en) 2023-11-15
US20240033124A1 (en) 2024-02-01
WO2022149914A1 (ko) 2022-07-14
CA3204104A1 (en) 2022-07-14
AU2022205341A1 (en) 2023-06-29
JP2024502964A (ja) 2024-01-24
KR20220100541A (ko) 2022-07-15

Similar Documents

Publication Publication Date Title
EA201390120A2 (ru) Доставка офтальмологических лекарственных средств
MX2021014960A (es) Conjugado de farmaco-anticuerpos anti-b7-h4 y uso medicinal del mismo.
RU2010104848A (ru) Кристаллическая форма 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
MX2012007410A (es) Compuestos antivirales novedosos.
AR026183A1 (es) Dispositivo y metodo de administracion de medicamentos oftalmicos
RU2009109358A (ru) Лечение глазных болезней
WO2010105130A3 (en) Opthalmic drug delivery system and applications
US20070021507A1 (en) Aqueous eye drops with accelerated intraocular migration
MX2023008097A (es) Composicion farmaceutica oftalmica y lentes de contacto de administracion de farmacos.
IL290069B2 (en) Methods for treating eye conditions
RU2015122256A (ru) Композиции, содержащие вортиоксетин и донепезил
RU2009103638A (ru) Трансмукозальное введение 2,3-диметокси-5-метил-6-(10-гидроксидецил)-1,4-бензохинона
Liu et al. Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body
ZA202201465B (en) Long-lasting formulation containing rivastigmine, and method for preparing same
RU2690490C2 (ru) Способ стабилизации дибутилгидрокситолуола
CN100352508C (zh) 一种眼用嵌段聚合物
MX2015009546A (es) Dosificacion aumentada de efavirenz para el tratamiento de cancer.
WO2018004576A3 (en) A fast acting orally disintegrating film for administration of local anesthesia
EA201070625A1 (ru) Система доставки лекарственного средства для введения водорастворимого катионного и амфифильного фармацевтически активного вещества
GB2590189A9 (en) Lycorine derivatives, pharmaceutical composite thereof and usage therefor
WO2014204357A3 (ru) Лекарственное средство для лечения кератоконуса
WO2020227578A1 (en) Lipoic acid formulations
MX2021008329A (es) Farmaco profilactico o terapeutico para enfermedades neurodegenerativas.
JP2014521648A5 (es)
RU2014106328A (ru) Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки